Can Novo Nordisk Stage a Turnaround on Wegovy Data and Robust Drug Pipeline? May 13, 2026 Life Science
Pfizer’s 6.7% Dividend: Can It Survive Plunging Profits and Cash Flow Crunch? May 12, 2026 Life Science
Hantavirus Fears Fuel Moderna Rally: Is This a Real Catalyst or Just Sentiment? May 11, 2026 Life Science
Eli Lilly’s Alzheimer’s Drug Kisunla Wins Health Canada Approval, Bolstering Global Footprint May 4, 2026 Life Science
GLP-1s and AI Are the Big Themes Behind These 5 Top-Rated Health Care Picks for 2026 May 4, 2026 Life Science
Want to Build Real Wealth in the Healthcare Sector? These Stocks Are Worth Considering Apr 30, 2026 Life Science
Bristol Myers Squibb Beats on Q1 Sales, Profit; Stock Jumps 5% as Growth Portfolio Shines Apr 30, 2026 Life Science
Shorted-to-The-Hilt KalVista Rockets 39% as Chiesi Swoops in With $1.9bn Cash Bid Apr 29, 2026 Life Science
High-Yield Healthcare Plays: MPT and Pfizer Offer 7% and 6.4% Dividends as Markets Turn Choppy Apr 28, 2026 Life Science, Real Estate
Organon Shares Extend Rally as India’s Sun Pharma Strikes $11.75 Billion All-Cash Deal Apr 27, 2026 Life Science
Trump Orders Fast-Track for Psychedelic Therapies—Who Stands to Win the Most? Apr 20, 2026 Life Science
Lilly in Advanced Talks to Acquire Kelonia for Over $2 Billion—Is a 39x P/E Still Too Rich? Apr 19, 2026 Life Science
